A phase II study of HyperAcute-lung cancer vaccine in subjects with advanced non-small cell lung cancer who responded to first line platinum-doublet treatment.
Phase of Trial: Phase II
Latest Information Update: 01 Jul 2015
At a glance
- Drugs Tergenpumatucel-L (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 10 Jul 2014 Planned End Date changed from 1 Dec 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov.
- 21 May 2013 Planned end date changed from 1 Dec 2011 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 27 May 2011 Planned end date changed from 1 Dec 2009 to 1 Dec 2011 as reported by ClinicalTrials.gov.